FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055087 [Registered on: 11/07/2023] Trial Registered Prospectively
Last Modified On: 08/07/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Exploring the Analgesic Efficacy of Ketamine- Dexmedetomidine (Ketodex) in Elective Laparoscopic Cholecystectomy :A Prospective Randomised Double Blind Controlled Study 
Scientific Title of Study   To evaluate the analgesic efficacy of Ketamine -Dexmedetomidine (Ketodex)in elective laproscopic cholecystectomy - Prospective Randomized double blind control study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr EKTA RANI 
Designation  JUNIOR RESIDENT  
Affiliation  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES SHEIKHPURA PATNA  
Address  DEPT.OF ANAETHESIA AND CRITICAL CARE MEDICINE ,INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES SHEIKHPURA PATNA
DEPT.OF ANAETHESIA AND CRITICAL CARE MEDICINE ,INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES SHEIKHPURA PATNA
Patna
BIHAR
800014
India 
Phone  7004111493  
Fax    
Email  rinkibuxar111@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mumtaz Hussain 
Designation  Additional Professor, Department of anaesthesiology and CCM 
Affiliation  Indira Gandhi institute of medical sciences, Sheikhpura,Patna 
Address  Department of anaesthesiology and CCM, 1st floor,OT complex,Indira Gandhi institute of medical sciences,Sheikhpura,Patna
Department of anaesthesiology and CCM, 1st floor,OT complex,Indira Gandhi institute of medical sciences,Sheikhpura,Patna
Patna
BIHAR
800014
India 
Phone  8544413239  
Fax    
Email  drhussain72@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mumtaz Hussain 
Designation  Additional Professor, Department of anaesthesiology and CCM 
Affiliation  Indira Gandhi institute of medical sciences, Sheikhpura,Patna 
Address  Department of anaesthesiology and CCM, 1st floor,OT complex,Indira Gandhi institute of medical sciences,Sheikhpura,Patna
Department of anaesthesiology and CCM, 1st floor,OT complex,Indira Gandhi institute of medical sciences,Sheikhpura,Patna
Patna
BIHAR
800014
India 
Phone  8544413239  
Fax    
Email  drhussain72@yahoo.co.in  
 
Source of Monetary or Material Support  
Indira Gandhi Institute Of Medical Sciences Patna 
 
Primary Sponsor  
Name  Indira Gandhi Institute of Medical Sciences Patna 
Address  Indira Gandhi Institute of Medical Sciences Sheikhpura Patna 800014  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr EKTA RANI  Indira Gandhi institute of medical sciences, Sheikhpura,Patna  Department of anaesthesiology and CCM, 1st floor,OT complex,Indira Gandhi institute of medical sciences,Sheikhpura,Patna Patna BIHAR 800014 India
Patna
BIHAR 
7004111493

rinkibuxar111@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute of ethics committee Indira Gandhi Institute Of Medical Sciences patna  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Infusion of Ketamine(K)  Group K will receive intravenous Ketamine 0.5 mg/kg in 10 ml normal saline over 10 minutes before skin incision  
Intervention  Ketamine-dexmedetomidine (KD)infusion vs Ketamine (K) infusion   Group KD Patients will be receive intravenous bolus inj Ketamine - dexmedetomidine (0.5 mg/kg + 0.5 mcg/kg) in 10 ml normal saline over 10 minutes before skin incision 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  AS A 1 & 2
Patients having no any co morbidities
Patients willing to participate in the trial  
 
ExclusionCriteria 
Details  ASA 3 & 4
Patients having college morbidities
Patients not willing to participate in the trial  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Visual analogue scale at 0 minute,30 minutes.1hr,2 hr ,4 hr ,6 hr ,8 hr ,12 hr,and 24 hr
Time of first rescue analgesia (inj Tramadol )
Total does of rescue analgesia (Inj.Tramadol) 
Visual analogue scale at 0 minute,30 minutes.1hr,2 hr ,4 hr ,6 hr ,8 hr ,12 hr,and 24 hr
Time of first rescue analgesia (inj Tramadol )
Total does of rescue analgesia (Inj.Tramadol) 
 
Secondary Outcome  
Outcome  TimePoints 
1. To assess the side effects of adding ketamine & dexmedetomidine if any (nausea vomiting, & bradycardia).  post-operatively 
 
Target Sample Size   Total Sample Size="102"
Sample Size from India="102" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   19/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients will be  randomly     divided into two Group  based on computer generated random numbers. Before skin incision study drugs will be given by anaesthesiologist who will not participate in study.
Group KD Patients will be received intravenous bolus inj. Ketamine -dexmedetomidine (0.5mg/kg +0.5microgram/kg) in 10 ml over 10 minutes before skin incision. 
Group K Patients will be received intravenous bolus ketamine (0.5mg/kg)in 10 ml over 10 minutes before skin incision .
Postoperative pain will be assessed using visual analogue scale at 0 minutes,30 minutes,1hr, 2hr,4hr,6hr,8hr, 12hr and 24 hr.
 
Close